Novosanis is an innovative developer and producer of medical devices adding value to the accuracy of diagnostics tests, vaccination based actions and the overall patient’s comfort.
We are a medical device company active in the field of infectious diseases and oncology in the areas of prevention, detection and treatment.
Novosanis prospers in user-friendly and smart medical devices meeting all regulatory and quality requirements, solutions that can improve the accuracy of the diagnostic test while making the handling easier, more consistent and more comfortable for the person.
Currently we have two device platforms in portfolio: VAX-ID™, suited for accurate intradermal injections and Colli-Pee™, suited for standardized collection of first void urine. Colli-Pee™ is in commercial stage and is CE marked.